Molecular Endocrinology, Vol 3, 509-517, Copyright © 1989 by Endocrine Society

ARTICLES

Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer

D Yee, S Paik, GS Lebovic, RR Marcus, RE Favoni, KJ Cullen, ME Lippman and N Rosen
Medical Breast Cancer Section, National Cancer Institute, Bethesda, Maryland 20892.

Insulin-like growth factor I (IGF-I) activity has been reported to be produced by several human cancers. Identification of RNAs transcribed from the IGF-I gene has been complicated by the detection of multiple hybridizing bands on Northern analysis. To determine if any of these RNAs are transcribed from the IGF-I gene, we have used a sensitive and specific ribonuclease (RNAse) protection assay for IGF-I. We have also studied the breast cancer tissue expression of IGF-I using in situ hybridization histochemistry. We have found no IGF-I mRNA in breast (zero of 11) or colon cancer (zero of 9) cell lines; both of these tumors have been previously reported to express IGF-I mRNA. However, three of three neuroepithelioma and one of two Ewing's sarcoma cell lines express IGF-I mRNA; therefore, in these tumors IGF-I may be an autocrine growth factor. In contrast to breast cancer cell lines, RNA extracted from breast tissues has easily detectable IGF-I mRNA. In situ hybridizations show that IGF-I mRNA is expressed in the stromal cells, and not by normal or malignant epithelial cells. These findings suggest that although IGF-I is not produced by breast epithelial cells it may function as either a paracrine stimulator of epithelial cells or an autocrine stimulator of stromal cells.

This article has been cited by other articles:

				L. N. Harris, F. You, S. J. Schnitt, A. Witkiewicz, X. Lu, D. Sgroi, P. D. Ryan, S. E. Come, H. J. Burstein, B.-A. Lesnikoski, et al. Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer Clin. Cancer Res., February 15, 2007; 13(4): 1198 - 1207. [Abstract] [Full Text] [PDF]

				A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights Endocr. Rev., February 1, 2007; 28(1): 20 - 47. [Abstract] [Full Text] [PDF]

				S. Maor, D. Mayer, R. I Yarden, A. V Lee, R. Sarfstein, H. Werner, and M. Z Papa Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1 J. Endocrinol., December 1, 2006; 191(3): 605 - 612. [Abstract] [Full Text] [PDF]

				J. M. Carboni, A. V. Lee, D. L. Hadsell, B. R. Rowley, F. Y. Lee, D. K. Bol, A. E. Camuso, M. Gottardis, A. F. Greer, C. P. Ho, et al. Tumor Development by Transgenic Expression of a Constitutively Active Insulin-Like Growth Factor I Receptor Cancer Res., May 1, 2005; 65(9): 3781 - 3787. [Abstract] [Full Text] [PDF]

				L-T Busund, E Richardsen, R Busund, T Ukkonen, T Bjornsen, C Busch, and H Stalsberg Significant expression of IGFBP2 in breast cancer compared with benign lesions J. Clin. Pathol., April 1, 2005; 58(4): 361 - 366. [Abstract] [Full Text] [PDF]

				A. M. Valverde, C. Mur, M. Brownlee, and M. Benito Susceptibility to Apoptosis in Insulin-like Growth Factor-I Receptor-deficient Brown Adipocytes Mol. Biol. Cell, November 1, 2004; 15(11): 5101 - 5117. [Abstract] [Full Text] [PDF]

				H.-S. Kim, A. R. Ingermann, J. Tsubaki, S. M. Twigg, G. E. Walker, and Y. Oh Insulin-Like Growth Factor-Binding Protein 3 Induces Caspase-Dependent Apoptosis through a Death Receptor-Mediated Pathway in MCF-7 Human Breast Cancer Cells Cancer Res., March 15, 2004; 64(6): 2229 - 2237. [Abstract] [Full Text] [PDF]

				A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF]

				M. P. Cleary, M. K. Jacobson, F. C. Phillips, S. C. Getzin, J. P. Grande, and N. J. Maihle Weight-Cycling Decreases Incidence and Increases Latency of Mammary Tumors to a Greater Extent Than Does Chronic Caloric Restriction in Mouse Mammary Tumor Virus- Transforming Growth Factor-{alpha} Female Mice Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 836 - 843. [Abstract] [Full Text] [PDF]

				R. T. Chlebowski, E. Aiello, and A. McTiernan Weight Loss in Breast Cancer Patient Management J. Clin. Oncol., February 15, 2002; 20(4): 1128 - 1143. [Abstract] [Full Text] [PDF]

				R. Clarke, F. Leonessa, J. N. Welch, and T. C. Skaar Cellular and Molecular Pharmacology of Antiestrogen Action and Resistance Pharmacol. Rev., March 1, 2001; 53(1): 25 - 72. [Abstract] [Full Text] [PDF]

				Y. Wang, S. W. Hayward, A. A. Donjacour, P. Young, T. Jacks, J. Sage, R. Dahiya, R. D. Cardiff, M. L. Day, and G. R. Cunha Sex Hormone-induced Carcinogenesis in Rb-deficient Prostate Tissue Cancer Res., November 1, 2000; 60(21): 6008 - 6017. [Abstract] [Full Text]

				H. M. Khandwala, I. E. McCutcheon, A. Flyvbjerg, and K. E. Friend The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth Endocr. Rev., June 1, 2000; 21(3): 215 - 244. [Abstract] [Full Text]

				R. E. Favoni and A. De Cupis The Role of Polypeptide Growth Factors in Human Carcinomas: New Targets for a Novel Pharmacological Approach Pharmacol. Rev., June 1, 2000; 52(2): 179 - 206. [Abstract] [Full Text] [PDF]

				J. DiGiovanni, D. K. Bol, E. Wilker, L. Beltrán, S. Carbajal, S. Moats, A. Ramirez, J. Jorcano, and K. Kiguchi Constitutive Expression of Insulin-like Growth Factor-1 in Epidermal Basal Cells of Transgenic Mice Leads to Spontaneous Tumor Promotion Cancer Res., March 1, 2000; 60(6): 1561 - 1570. [Abstract] [Full Text]

				A. Vogt, A. S. Wang, C. S. Johnson, J. P. Fabisiak, P. Wipf, and J. S. Lazo In Vivo Antitumor Activity and Induction of Insulin-Like Growth Factor-1-Resistant Apoptosis by SC-alpha alpha delta 9 J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 530 - 537. [Abstract] [Full Text]

				N. Farrelly, Y.-J. Lee, J. Oliver, C. Dive, and C. H. Streuli Extracellular Matrix Regulates Apoptosis in Mammary Epithelium through a Control on Insulin Signaling J. Cell Biol., March 22, 1999; 144(6): 1337 - 1348. [Abstract] [Full Text] [PDF]

				A. J. Butt, S. M. Firth, M. A. King, and R. C. Baxter Insulin-like Growth Factor-binding Protein-3 Modulates Expression of Bax and Bcl-2 and Potentiates p53-independent Radiation-induced Apoptosis in Human Breast Cancer Cells J. Biol. Chem., December 8, 2000; 275(50): 39174 - 39181. [Abstract] [Full Text] [PDF]